Oscar Health, INC Form 4 insider transactions

NYSE
Director William Gassen acquired 8,974 shares of Oscar Health's Class A common stock on June 6, 2024, through restricted stock units.
NYSE
Director David Plouffe acquired 8,974 shares of Oscar Health's Class A common stock on June 6, 2024, through the vesting of restricted stock units.
NYSE
Vanessa Ames Wittman, a director at Oscar Health, Inc., reported the acquisition of 8,974 restricted stock units (RSUs) on June 6, 2024.
NYSE
Director Jeffrey Boyd reports the acquisition of 8,974 restricted stock units (RSUs) in Oscar Health, Inc.
NYSE
Laura Lang, a director at Oscar Health, Inc., reported the acquisition of 8,974 restricted stock units (RSUs) on June 6, 2024.
NYSE
EVP, Chief Insurance Officer of Oscar Health, Alessandrea C. Quane, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
Richard Scott Blackley, CFO of Oscar Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
Alessandrea Quane, EVP and Chief Insurance Officer at Oscar Health, reports multiple transactions involving Class A Common Stock, including acquisitions through restricted stock unit vesting and sales to cover tax obligations.
NYSE
Steven Wolin, Chief Operating Officer of Oscar Health, Inc., reported the acquisition and disposition of Class A Common Stock and Restricted Stock Units.
NYSE
Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., reported the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.
NYSE
Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, Inc., reported the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.
NYSE
Richard Blackley, CFO of Oscar Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.
NYSE
Oscar Health's Chief Operating Officer, Steven Wolin, acquired 17,521 restricted stock units on May 3, 2024, which will vest over a three-year period.
NYSE
Director Jeffery H. Boyd received 2,080 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments for board service.
NYSE
Oscar Health's CEO, Mark Bertolini, vested 955,555 restricted stock units on April 3, 2024, which convert to Class A common stock.
NYSE
Mario Schlosser, President of Technology & CTO of Oscar Health, received two grants of restricted stock units, one representing the standard annual award and another pulled forward from 2025 to incentivize retention.
NYSE
Richard Scott Blackley, CFO of Oscar Health, Inc., was granted 103,829 restricted stock units (RSUs) on March 10, 2024, which will vest quarterly over three years.
NYSE
Alessandrea C. Quane, EVP and Chief Insurance Officer of Oscar Health, Inc., acquired 103,829 restricted stock units on March 10, 2024.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., acquired 10,652 restricted stock units (RSUs) on March 10, 2024, which will vest quarterly over three years.
NYSE
Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, Inc., acquired 58,404 restricted stock units (RSUs) on March 10, 2024, which will vest quarterly over three years.
NYSE
Richard Blackley, CFO of Oscar Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
EVP and Chief Insurance Officer of Oscar Health, Alessandrea C. Quane, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.
NYSE
Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, reports the vesting and sale of Class A Common Stock to cover tax obligations.
NYSE
Richard Blackley, CFO of Oscar Health, reports the vesting and sale of Class A Common Stock to cover tax obligations.
NYSE
Alessandrea C. Quane, EVP and Chief Insurance Officer at Oscar Health, reported the acquisition and disposal of Class A Common Stock and Restricted Stock Units on March 1 and March 4, 2024.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, reports the acquisition and disposal of Class A Common Stock, including transactions related to restricted stock units and tax obligations.